# OnCo record nct05257590 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05257590/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05257590", "NCT05257590" ;
  schema:name "CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma"@en ;
  schema:description "A phase 2 trial of Nivolumab in hepatocellular carcinoma and metastatic cancer, run by TaiRx, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05257590/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05257590> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-05-23" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/hcc-advanced/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:companies <https://onco.cc/companies/tairx/> .